- Home
- NKTR vs VATE Comparison
NKTR vs VATE Comparison
Compare NKTR & VATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKTR
- VATE
- Stock Information
- Founded
- NKTR 1990
- VATE 1994
- Country
- NKTR United States
- VATE United States
- Employees
- NKTR N/A
- VATE N/A
- Industry
- NKTR Biotechnology: Pharmaceutical Preparations
- VATE Metal Fabrications
- Sector
- NKTR Health Care
- VATE Industrials
- Exchange
- NKTR Nasdaq
- VATE Nasdaq
- Market Cap
- NKTR 108.3M
- VATE 98.2M
- IPO Year
- NKTR 1994
- VATE 1996
- Fundamental
- Price
- NKTR $23.47
- VATE $5.29
- Analyst Decision
- NKTR Strong Buy
- VATE
- Analyst Count
- NKTR 6
- VATE 0
- Target Price
- NKTR $77.50
- VATE N/A
- AVG Volume (30 Days)
- NKTR 4.6M
- VATE 18.1K
- Earning Date
- NKTR 08-07-2025
- VATE 08-06-2025
- Dividend Yield
- NKTR N/A
- VATE N/A
- EPS Growth
- NKTR N/A
- VATE N/A
- EPS
- NKTR N/A
- VATE N/A
- Revenue
- NKTR $87,248,000.00
- VATE $1,066,100,000.00
- Revenue This Year
- NKTR N/A
- VATE N/A
- Revenue Next Year
- NKTR N/A
- VATE N/A
- P/E Ratio
- NKTR N/A
- VATE N/A
- Revenue Growth
- NKTR N/A
- VATE N/A
- 52 Week Low
- NKTR $6.48
- VATE $3.25
- 52 Week High
- NKTR $37.38
- VATE $13.79
- Technical
- Relative Strength Index (RSI)
- NKTR 64.13
- VATE 44.64
- Support Level
- NKTR $8.27
- VATE $5.04
- Resistance Level
- NKTR $26.59
- VATE $5.62
- Average True Range (ATR)
- NKTR 3.81
- VATE 0.23
- MACD
- NKTR 0.81
- VATE 0.05
- Stochastic Oscillator
- NKTR 52.67
- VATE 43.10
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.
About VATE INNOVATE Corp.
Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting station across the United States.